University of Texas Southwestern Medical Center (UT Southwestern)

Impact of Oral Semaglutide on Kidney Outcomes in People With Type 2 Diabetes: Results From the SOUL Randomized Trial. Diabetes Care 2026;49:257–265 (2026) Mann JF, Jeppesen OK, Belmar N, McGuire DK, Buse JB Journal article Safety of Semaglutide After Dialysis Initiation: An Individual-Level Pooled Analysis (2026) Klein KR, Menacher A, Buse JB, Mann J, Tuttle KR, Kvist K, Andersen MR, et al. Journal article Effect of Oral Semaglutide on Cardiovascular Outcomes in Type 2 Diabetes by Extent of Vascular Disease (2026) Cavender MA, Marx N, Mulvagh SL, Deanfield JE, Buse JB, Inzucchi SE, Pop-Busui R, et al. Journal article ASO Visual Abstract: Surgical Outcomes After Neoadjuvant Pembrolizumab Plus Chemotherapy for Triple-Negative Breast Cancer-Results from the Randomized, Placebo-Controlled Phase 3 KEYNOTE-522 Study (2026) Kuemmel S, Fasching P, Schmid P, Harbeck N, Takahashi M, Untch M, Boileau JF, et al. Journal article Immune checkpoint inhibitor-associated myocarditis: A novel risk score (2026) Power JR, Dolladille C, Ozbay B, Procureur A, Ederhy S, Palaskas NL, Lehmann LH, et al. Journal article Impact of Oral Semaglutide on Kidney Outcomes in People With Type 2 Diabetes: Results From the SOUL Randomized Trial (2026) Mann JF, Marx N, Deanfield JE, Emerson SS, Inzucchi SE, McGuire DK, Mulvagh SL, et al. Journal article Risk Prognostication After Hypomethylating Agents Combined With Venetoclax in AML: The PRISM Risk Model. (2026) Lachowiez CA, Zeidner JF, Othman J, Kaempf A, Yun S, Heiblig M, Heuser M, et al. Journal article Multinational validation of the PREVENT and SCORE2 cardiovascular risk equations across 6.4 million individuals (2026) Neuen BL, Major RW, Grams ME, Sang Y, Coresh J, Ballew SH, Surapaneni A, et al. Journal article Safety and Synergy of Finerenone and Empagliflozin in Lowering Blood Pressure (2026) Agarwal R, Correa-Rotter R, Navaneethan SD, Heerspink HJ, Weir MR, McGill JB, Mottl AK, et al. Journal article Impact of Simultaneous Initiation of Finerenone and Empagliflozin on Albuminuria Irrespective of Baseline HbA1c Levels: A Participant-Level Exploratory Analysis of the Randomised CONFIDENCE Trial (2026) McGill JB, Green JB, Heerspink HJ, Mann JF, Mottl AK, Rosenstock J, Rossing P, et al. Journal article